Kate Harrison
Gary Volpe, of Signal Mountain, injured his back while working as a cook last July. When the pain sharpened, doctors at Chattanooga Neurosurgery and Spine (CNS) diagnosed him with a herniated disc and a pinched nerve in his neck.
Doctors with the surgery group recommended steroid injections, saying the pain would be alleviated.
But after receiving the injections from one of those doctors at an outpatient facility, Chattanooga Surgery Center, the ache only got worse.
"I started to get terrible headaches and pain began to shoot up and down my arm," Volpe said in a statement. "I was forgetting things and struggled with admitting it. It was so irritating my wife actually thought I was getting early onset Alzheimer's disease and she insisted I see my internist."
In October, he received letters from both CNS and the Chattanooga Surgery Center, warning that the medication he received was from the New England Compounding Center -- the Massachusetts drug manufacturer at the root of last year's devastating meningitis outbreak.
More than 700 patients nationwide have confirmed illnesses related to tainted NECC products. At least 58 people died after exposure to the drug -- 15 of whom were from Tennessee.
While the drug Volpe was treated with was not the one directly linked to the meningitis outbreak, officials cautioned "out of an abundance of caution" that other products from the NECC could be affected.
His current doctor has since told him that there could be long-term consequences from tainted steroid injections. He's now out of work as a result of his illness, he said.
"I feel as if my life has been devastated," said Volpe, describing a daily battle with headaches, pain, fatigue and memory problems. "The fear of the next symptom or injury that is to come weighs heavy on me every day."
CNS and Erlanger Health System were among dozens of hospitals and clinics served subpoenas in June, in connection with a large, multidistrict federal lawsuit against the New England Compounding Center.
continue to read here
No comments:
Post a Comment